Price: 6.95

Today's Change: 0.07

Today's Percent Change: 0.49%

Today's Volume: 2698792

Average Daily Volume: 4635450

52 week low: 5.85

52 week high: 12.15

Market cap: 3890000000.0

EBITDA: -17020000.0

EBITDA / market_cap: -0.44%

Earnings per Share (EPS): -0.15

EPS / price: -2.16%

Dividend Yield: 0.0%

Dividend per share: 0.0

Book value: 3.77

Price to Book Ratio: 1.83

Price to Earnings (P/E) Ratio: 0.0

Price to Earnings Growth (PEG) Ratio: -2.87

Price to Sales (P/S) Ratio: 3.25

Short Ratio: 18.7

Exchange: "NMS"

Short term: DOWN (Previous: UP)

Mid term: DOWN (Previous: UP)

Long term: DOWN (Previous: UP)

Support: 7.69

Resistance: 8.02

Pivot point: 7.86

SMA 10: 8.01

SMA 50: 8.43

SMA 100: 9.44

RSI 10: 41.69

RSI 50: 42.95

RSI 100: 44.54

EMA 10: 8.00

EMA 50: 8.53

EMA 100: 9.66

STRONG SELL

Based on 0 buy signals and 12 sell signals

Previous signal: strong sell

9.01

POSITIVE

OPK
OPK

@LaceeeyEvans: https://t.co/WgdnrCX36K $BXEFF has always been a favorite of mine. Especially now with the rise of oil over the la… https://t.co/MDxismatcg

@LaceeeyEvans: hope y'all have been making moolah! i most definitely am, and i'm in the zone, just because these are on my watchl… https://t.co/vbJ1eFib82

@zoneblitzzzz: RT @TickerReport: Opko Health Inc. $OPK CEO Phillip Md Et Al Frost Purchases 40,000 Shares https://t.co/D0z1xDnyrn

@zoneblitzzzz: RT @GiDunham: $OPK today announced positive topline results from a Phase 2 dose escalation trial of OPK88003 to treat type 2 diabetes and o…

@zoneblitzzzz: RT @274MicroCap: #biotech highlights $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Suffer…

@stocktrader8000: $SEEL Watching for breakout to 4.20 area or possibly 7.50. On watch: $BPTH $RKDA $TENX (all from earlier) $OPK and $CNAT time to buy!

@IQStockAlerts1: RT @247Biotech: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers $BIIB Alzheimer’s f…

@YuZhu4: RT @crusadernz: Biotech updates 03/21: $BIIB Alzheimer’s fail -29% $CNAT NASH fail -51% $BPMX offering $OPK +11% primary met Pipeline upda…

@aliontario: Bought $opk 2.63

@FuzzyPandaShort: $RDVT-The fund that wrote the rebuttal to our $RDVT short article flipped their position and now is SHORT Article… https://t.co/jBHlxnrtUv

@QuantchaIdeas: Covered Call Alert: OPKO HEALTH $OPK returning up to 33.93% through 20-Sep-2019 https://t.co/mxOZWIefa9 https://t.co/YoIVSS6KXV

@ITPSTweets: RT @MomentumBeats: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market $BIIB Alzheimer’s fail -29% $CNAT NASH fail -51%…

@ITPSTweets: RT @247Biotech: $QBIO Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market $BIIB Alzheimer’s fail -29% $CNAT NASH fail -51% $B…

@ITPSTweets: RT @247Biotech: $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers $BIIB Alzheimer’s f…

@ITPSTweets: RT @274MicroCap: #biotech highlights $QBIO Q BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Suffer…